Tag Archives: ASA

Post TAVR ASA Monotherapy Consolidates

Post TAVR ASA Monotherapy Consolidates

This meta-analysis to be published in J Am Cardiol supports the use of aspirin monotherapy (ASA) after transcatheter aortic valve replacement (TAVR). The use of aspirin alone is associated to less bleeding without increased ischemic events such as strokes or mortality.  The combined outcomes of four studies, including the recently published POPular TAVI (cohort A),

Evolución de pacientes jóvenes con miocardiopatía hipertrófica tratados con ablación septal por alcoholización.

Progress of patients with hypertrophic cardiomyopathy treated with alcohol septal ablation

Courtesy of Dr. José Álvarez. Alcohol septal ablation (ASA) for the treatment of obstructive hypertrophic cardiomyopathy (OHC) is a procedure introduced in 1995 as an alternative to surgical myectomy.   The American College of Cardiology (ACC)/American Heart Association (AHA) guidelines indicate that ASA should be reserved for older patients with comorbidities, thus establishing surgical myectomy